Bixiye
2017 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 16, Feb 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3351 - 3360 ee natiijooyinka 3469
Bixiye
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2017
Bixiye
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2017
Bixiye
P2-17 Updated: Change in Coverage for Detoxification Services for Minnesota Health Care Programs Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2017
Bixiye
P3-17 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2017
Bixiye
P1-17 Prior Authorization Requirement for Gender Dysphoria
Taariikhda uu dhaqangalayo Barnaamijka: Jan 18, 2017
Bixiye
QP1-17 2017 Commercial Network Guide
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2017
Bixiye
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Taariikhda uu dhaqangalayo Barnaamijka: Des 20, 2016
Bixiye
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016
Bixiye
QP40-16 Medicare Outpatient Observation Notice (MOON) CMS-10611
Taariikhda uu dhaqangalayo Barnaamijka: Des 15, 2016